Skip to main content
All lobbying filings

VENABLE LLP

VENABLE LLP filed a Q3 report for THE DIATRIBE FOUNDATION on October 6, 2025, reporting $20,000 in lobbying income.

Lobbying for THE DIATRIBE FOUNDATION · Diabetes nonprofit

All filings by VENABLE LLP · Everything THE DIATRIBE FOUNDATION has reported

 Filing · LD-2 quarterly report Q3 report
Reporting period
3rd Quarter 2025
July 1 - Sep 30 · Posted Oct 6, 2025
Income
$20,000
What the client paid this registrant for the period.
Client based in
California

Official filing document

 Government bodies contacted 2

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when. Each name opens every filing that named the same body.

 Lobbying activity 1

Advancing policies and programs to improve access to care and expand treatment options for individuals living with diabetes and obesity; The Special Diabetes Program Reauthorization Act (H.R. 2550); FDA guidance on diabetes endpoints; Policy related to the use of Continuous Glucose Monitors; The Centers for Medicare and Medicaid Services (CMS) competitive bidding proposal.

 Bills named in this filing 1
  • H.R. 2550
    Special Diabetes Program Reauthorization Act of 2023

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.

Report a problem